Clinical trial
GIP: Glucose-dependent Insulinotropic Peptide
NCT00239707 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00239707 |
|---|---|
| Title | GIP: Glucose-dependent Insulinotropic Peptide |
| Official title | Effect of GIP / GIP Analog in Type 2 Diabetes After a Meal |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | GIP, Modified GIP, Normal Saline |
| Enrollment | 41 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | Nov 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: